Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Prolonged skin staining after intradermal use of patent blue purported
July 14th, 2005
Prolonged skin staining occurred after intradermal use of patent blue in sentinel lymph node biopsy (SLNB) for breast cancer. In a recent report, researchers in the Netherlands conducted a study "to investigate the duration of staining of the skin after intradermal injection of patent blue during SLNB for breast cancer." "The clinical data of 33 consecutive patients who underwent a SLNB in combination with breast conserving therapy (BCT) in our hospital were retrospectively reviewed," explained G.A.M. Govaert and colleagues, Albert Schweitzer Hospital. "Also, patients were interviewed at intervals of 3 months until the blue...
Source: Women's Health Weekly (2005-07-14)
|
